Advertisement
Canada markets open in 3 hours 39 minutes
  • S&P/TSX

    21,953.80
    +78.01 (+0.36%)
     
  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     
  • DOW

    39,331.85
    +162.33 (+0.41%)
     
  • CAD/USD

    0.7310
    -0.0000 (-0.01%)
     
  • CRUDE OIL

    82.92
    +0.11 (+0.13%)
     
  • Bitcoin CAD

    82,784.80
    -2,774.26 (-3.24%)
     
  • CMC Crypto 200

    1,305.10
    -29.82 (-2.23%)
     
  • GOLD FUTURES

    2,353.00
    +19.60 (+0.84%)
     
  • RUSSELL 2000

    2,033.87
    +3.81 (+0.19%)
     
  • 10-Yr Bond

    4.4360
    -0.0430 (-0.96%)
     
  • NASDAQ futures

    20,264.00
    +8.75 (+0.04%)
     
  • VOLATILITY

    12.12
    +0.09 (+0.75%)
     
  • FTSE

    8,165.44
    +44.24 (+0.54%)
     
  • NIKKEI 225

    40,580.76
    +506.07 (+1.26%)
     
  • CAD/EUR

    0.6792
    -0.0008 (-0.12%)
     

Travere Therapeutics to Present at Upcoming Investor Conferences

Travere Therapeutics, Inc.
Travere Therapeutics, Inc.

SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences:

BofA Securities Health Care Conference
Wednesday, May 15, 2024, at 8:00 a.m. PT

Jefferies Global Healthcare Conference
Wednesday, June 5, 2024, at 3:00 p.m. ET

Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.

ADVERTISEMENT

Contact Info

Media:
888-969-7879                                        
mediarelations@travere.com

Investors:
888-969-7879                                        
IR@travere.com